The main objective of this retrospective study was to evaluate the prognostic value of HuR and two of its post-translational variants, methyl-HuR (mHuR) and phospho-HuR (pHuR), in a cohort of 89 cases of endometrioid endometrial adenocarcinomas. The gene discussed is ELAVL1; the disease is endometrial endometrioid adenocarcinoma.